speb/financial-data huggingface dataset:
Financial ratios for MAH.V — quarterly report dated 2025-09-30
Total revenue: 10503.597122302159
Gross profit: -5384.172661870504
Operating income: -107943.1654676259
Net income: -101468.34532374101
Capital expenditures: 197.12230215827338
Operating cash flow: 14961.870503597123
Depreciation & amortization: 2036.6906474820146
Net tangible assets: -1626095.6834532376
Owner earnings: -99628.77697841727
Buffett classification: The Gruesome
Stock price: 0.007194244604316547
Shares outstanding: 5284960
Book value: -1626095.6834532376
Market cap (USD): 38021.29496402878
Debt to equity: -0.6901821151692737
Current ratio: 0.09837411138977167
Quick ratio: 0.09837411138977167
Interest coverage ratio: -3.1956253194752087
COGS to revenue (%): 151.26027397260273
SG&A to revenue (%): 952.2671232876712
Free cash flow (dilution-adjusted): 14764.74820143885
Buyback yield (%): 0
Retained earnings: -24996892.8057554
Receivables turnover: 0.9682339677697459
Capitalized R&D asset: 0
FCF margin (%): 140.56849315068493
Revenue growth (%): -59.721412815445454
Rule of 40 score: 80.84708033523947
Financial ratios for MEDPLUS.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.378610048793353
Shares outstanding: 120085800
Market cap (USD): 1606581090.597389
Buyback yield (%): 0
Retained earnings: 21597784.518000793
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEDPLUS.NS — annual report dated 2023-03-31
Total revenue: 551605359.3179051
Gross profit: 118269427.5274056
Operating income: 10637271.61997564
Net income: 6102923.264311816
Capital expenditures: 20565773.447015837
Operating cash flow: 11011936.662606578
Depreciation & amortization: 22172350.791717418
Net tangible assets: 175662484.77466506
Owner earnings: 7709500.609013397
Return on net tangible assets (%): 4.388814503508208
Capex to operating income (%): 193.33692117436908
Buffett classification: The Gruesome
Stock price: 7.913520097442145
P/E ratio: 155.712492286199
Shares outstanding: 120085800
Book value: 181547015.83434835
P/B ratio: 5.234464402237906
Market cap (USD): 950301391.717418
Debt to equity: 0.6037728253788492
Current ratio: 3.1069530386102735
Quick ratio: 0.7063491563903874
Effective tax rate (%): -6.237940758645548
Interest coverage ratio: 1.0518506028159513
COGS to revenue (%): 78.55905031929834
SG&A to revenue (%): 1.9588268546243053
Free cash flow (dilution-adjusted): -12267478.684531061
Buyback yield (%): 0
Retained earnings: 26050304.50669915
Inventory turnover: 3.1096306487181486
Receivables turnover: 677.5403949730701
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.764091313652007
FCF margin (%): -2.2239592993985
Rule of 40 score: -2.2239592993985
Financial ratios for MEDPLUS.NS — annual report dated 2024-03-31
Total revenue: 668370548.0273414
Gross profit: 141733301.35507855
Operating income: 15773474.037654394
Net income: 7863892.553063916
Capital expenditures: 9934404.60486869
Operating cash flow: 17236719.03105888
Depreciation & amortization: 26887396.570332173
Net tangible assets: 183043770.23623934
Owner earnings: 24816884.518527403
Return on net tangible assets (%): 13.557896281582444
Capex to operating income (%): 62.9817158931083
Buffett classification: The Good
Stock price: 8.251559500959694
P/E ratio: 126.00567940545866
Shares outstanding: 120085800
Book value: 189154454.97061998
P/B ratio: 5.238550284603417
Market cap (USD): 990895123.9203455
Debt to equity: 0.6400375564472006
Current ratio: 2.9805051955089508
Quick ratio: 0.43221690893361353
Effective tax rate (%): 10.710346799558842
Interest coverage ratio: 1.3640040235189197
COGS to revenue (%): 78.79420304000581
SG&A to revenue (%): 2.2142472417001615
Free cash flow (dilution-adjusted): 5424391.41383859
Buyback yield (%): 0
Retained earnings: 33492145.341168005
Inventory turnover: 3.2767621176600503
Receivables turnover: 454.94588196881887
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.306256973955026
FCF margin (%): 0.8115844466588751
Revenue growth (%): 21.168247685958644
Rule of 40 score: 21.979832132617517
Financial ratios for MEDPLUS.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 189288342.09268993
Buffett classification: The Gruesome
Stock price: 8.01182513139035
Shares outstanding: 120085800
Book value: 195374104.15671286
P/B ratio: 4.924431692295277
Market cap (USD): 962106430.3631152
Debt to equity: 0.629554091529353
Current ratio: 3.039643135451965
Quick ratio: 0.6597680664452534
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEDPLUS.NS — quarterly report dated 2024-12-31
Total revenue: 182007926.3317403
Gross profit: 45560554.84322182
Operating income: 8165870.148035901
Net income: 5348642.032870963
Capital expenditures: 0
Depreciation & amortization: 7281617.904184637
Owner earnings: 12630259.937055599
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.684695185919104
P/E ratio: 54.35932906006189
Shares outstanding: 120085800
Market cap (USD): 1162994369.1572442
Effective tax rate (%): 18.957597173144876
Interest coverage ratio: 2.697431750798968
COGS to revenue (%): 74.96781829150673
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEDPLUS.NS — annual report dated 2025-03-31
Total revenue: 711651157.353285
Gross profit: 169137596.44610706
Operating income: 27883680.149637595
Net income: 17573299.041384146
Capital expenditures: 6827449.146598082
Operating cash flow: 63178512.97638531
Depreciation & amortization: 29207739.069441196
Net tangible assets: 197529342.9974281
Owner earnings: 39953588.96422726
Return on net tangible assets (%): 20.22666018017762
Capex to operating income (%): 24.485466444739785
Buffett classification: The Great
Stock price: 8.869179600886918
P/E ratio: 60.606863014623656
Shares outstanding: 120085800
Book value: 203401800.3273322
P/B ratio: 5.236249266241465
Market cap (USD): 1065062527.7161863
Debt to equity: 0.6436017263071019
Current ratio: 3.1972514455578795
Quick ratio: 0.8644158628081456
Effective tax rate (%): 18.03490662287426
Interest coverage ratio: 2.325044353030628
COGS to revenue (%): 76.23307505391408
SG&A to revenue (%): 2.1769327917175363
Free cash flow (dilution-adjusted): 55425531.91489361
Buyback yield (%): 0
Retained earnings: 50240706.10240822
Inventory turnover: 3.4500516318873182
Receivables turnover: 765.14127702363
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.568956864035616
FCF margin (%): 7.788300678246311
Revenue growth (%): 6.475541068301695
Rule of 40 score: 14.263841746548007
Financial ratios for MEDPLUS.NS — quarterly report dated 2025-03-31
Total revenue: 176479892.44797754
Gross profit: 46875379.93920972
Operating income: 8436404.021510404
Net income: 6001285.948094458
Capital expenditures: 0
Depreciation & amortization: 7506312.83610007
Net tangible assets: 197529342.9974281
Owner earnings: 13507598.784194529
Return on net tangible assets (%): 6.838274546567193
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.869179600886918
P/E ratio: 44.368096143392705
Shares outstanding: 120085800
Book value: 203401800.3273322
P/B ratio: 5.236249266241465
Market cap (USD): 1065062527.7161863
Debt to equity: 0.6436017263071019
Current ratio: 3.1972514455578795
Quick ratio: 0.8644158628081456
Effective tax rate (%): 16.028535898946267
Interest coverage ratio: 2.6886107074997203
COGS to revenue (%): 73.43868511647717
Buyback yield (%): 0
Retained earnings: 50240706.10240822
Inventory turnover: 0.8242047611365408
Receivables turnover: 189.7447209653092
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5925983141374838
Revenue growth (%): -3.0372489787543473
Rule of 40 score: -3.0372489787543473
Financial ratios for MEDPLUS.NS — quarterly report dated 2025-06-30
Total revenue: 180509478.11841798
Gross profit: 47144629.06622982
Operating income: 7619003.042358999
Net income: 4956470.8635619
Capital expenditures: 0
Depreciation & amortization: 7678212.029019425
Owner earnings: 12634682.892581325
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.583898900070208
P/E ratio: 77.94338766346378
Shares outstanding: 120085800
Market cap (USD): 1270975966.534051
Effective tax rate (%): 19.753250198991775
Interest coverage ratio: 2.3793897314087338
COGS to revenue (%): 73.88246337109126
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.2833114948935447
Rule of 40 score: 2.2833114948935447
Financial ratios for MEDPLUS.NS — quarterly report dated 2025-12-31
Total revenue: 201193940.0690654
Gross profit: 52628049.459730424
Operating income: 9566113.400913445
Net income: 6439456.388548513
Capital expenditures: 0
Depreciation & amortization: 8103041.105046229
Owner earnings: 14542497.493594743
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.992982065277932
P/E ratio: 47.47807609907653
Shares outstanding: 120085800
Market cap (USD): 1079929445.6945527
Effective tax rate (%): 21.14836191957646
Interest coverage ratio: 2.7855266145512343
COGS to revenue (%): 73.84212991620703
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 11.458933994079787
Rule of 40 score: 11.458933994079787
Financial ratios for MF.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 95.43181818181819
Shares outstanding: 38928299
Market cap (USD): 3714998352.295455
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MF.PA — annual report dated 2022-12-31
Total revenue: 7177765957.446809
Operating income: 955212765.9574468
Net income: 1087340425.531915
Capital expenditures: 150106382.9787234
Operating cash flow: 1588617021.2765958
Depreciation & amortization: 623723404.2553192
Net tangible assets: -3032872340.425532
Owner earnings: 1560957446.8085108
Return on net tangible assets (%): -51.46795748710934
Capex to operating income (%): 15.714444815681034
Buffett classification: The Great
Stock price: 76.80851063829788
P/E ratio: 2.7498514703062322
Shares outstanding: 38928299
Book value: 4932234042.553192
P/B ratio: 0.6062211651101094
Market cap (USD): 2990024667.8723407
Debt to equity: 1.3078748139680347
Current ratio: 1.721704394141145
Quick ratio: 1.579061251664447
Effective tax rate (%): 41.52930402930403
Interest coverage ratio: 45.81122448979591
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 1302021276.5957448
Buyback yield (%): 2.5972887549234356
Retained earnings: 698191489.3617022
Inventory turnover: 0
Receivables turnover: 4.198830045429087
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.334570972413024
FCF margin (%): 18.139645180892533
Rule of 40 score: 18.139645180892533
Financial ratios for MF.PA — annual report dated 2023-12-31
Total revenue: 7924777777.777778
Gross profit: 8132555555.555555
Operating income: 964888888.8888888
Net income: 589888888.8888888
Capital expenditures: 224333333.3333333
Operating cash flow: 1568222222.222222
Depreciation & amortization: 659444444.4444444
Net tangible assets: -3424111111.111111
Owner earnings: 1025000000
Return on net tangible assets (%): -29.934776259856573
Capex to operating income (%): 23.249654537079685
Buffett classification: The Great
Stock price: 76.66666666666667
P/E ratio: 5.059432343190809
Shares outstanding: 38928299
Book value: 5368444444.444445
P/B ratio: 0.5559343966801887
Market cap (USD): 2984502923.3333335
Debt to equity: 1.265522808179485
Current ratio: 2.0371784791643264
Quick ratio: 1.9828990228013028
Effective tax rate (%): 36.01263097459452
Interest coverage ratio: 35.88429752066116
COGS to revenue (%): -2.6877725277960827
Free cash flow (dilution-adjusted): 1312333333.3333333
Buyback yield (%): 0.9307338103309115
Retained earnings: 3687444444.444444
Inventory turnover: -0.9917227108122091
Receivables turnover: 4.499022267078787
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.556889875125093
FCF margin (%): 16.55987549598306
Revenue growth (%): 10.407302561264999
Rule of 40 score: 26.96717805724806
Financial ratios for MF.PA — annual report dated 2024-12-31
Total revenue: 7454791666.666667
Gross profit: 7666666666.666667
Operating income: 880729166.6666667
Net income: 1031145833.3333334
Capital expenditures: 207187500
Operating cash flow: 1660000000
Depreciation & amortization: 776666666.6666667
Net tangible assets: -3056666666.666667
Owner earnings: 1600625000
Return on net tangible assets (%): -52.36504907306434
Capex to operating income (%): 23.524541691306915
Buffett classification: The Great
Stock price: 86.51041666666667
P/E ratio: 3.265981646580463
Shares outstanding: 38928299
Book value: 5383333333.333332
P/B ratio: 0.6255795727457433
Market cap (USD): 3367703366.6145835
Debt to equity: 1.3055147058823533
Current ratio: 2.0732440378961123
Quick ratio: 2.0166938908853314
Effective tax rate (%): 44.91353001017294
Interest coverage ratio: 3.3551587301587307
COGS to revenue (%): -2.842131738535058
Free cash flow (dilution-adjusted): 1445729166.6666667
Buyback yield (%): 8.772051291549385
Retained earnings: 3145520833.3333335
Inventory turnover: -1.175043327556326
Receivables turnover: 4.346289323454391
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.8201434206387
FCF margin (%): 19.393287315205544
Revenue growth (%): -5.930590412629861
Rule of 40 score: 13.462696902575683
Financial ratios for MF.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -3056666666.666667
Buffett classification: The Gruesome
Stock price: 86.51041666666667
Shares outstanding: 38928299
Book value: 5383333333.333332
P/B ratio: 0.6255795727457433
Market cap (USD): 3367703366.6145835
Debt to equity: 1.3055147058823533
Current ratio: 2.0732440378961123
Quick ratio: 2.0166938908853314
Buyback yield (%): 0
Retained earnings: 3145520833.3333335
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MF.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -4390470588.235294
Buffett classification: The Gruesome
Stock price: 99.25882352941177
Shares outstanding: 38928299
Book value: 5504117647.058825
P/B ratio: 0.7020157286801324
Market cap (USD): 3863977160.7411766
Debt to equity: 1.4168643796088487
Quick ratio: 0
Buyback yield (%): 0
Retained earnings: 4623529411.764706
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MGG.V — annual report dated 2022-04-30
Total revenue: 0
Operating income: -6635780.46875
Net income: -5137221.875
Capital expenditures: 0
Operating cash flow: -4776158.59375
Net tangible assets: 12401832.03125
Owner earnings: -5137221.875
Return on net tangible assets (%): -41.42308863767292
Buffett classification: The Gruesome
Stock price: 0.234375
Shares outstanding: 511063160
Book value: 12401832.03125
P/B ratio: 9.65828498750657
Market cap (USD): 119780428.125
Debt to equity: 0
Current ratio: 14.19678433554982
Quick ratio: 14.19678433554982
Free cash flow (dilution-adjusted): -6491502.34375
Buyback yield (%): 0
Retained earnings: -39114025
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -52.83742899452547
Rule of 40 score: 0
Financial ratios for MGG.V — annual report dated 2023-04-30
Total revenue: 0
Operating income: -4073997.058823529
Net income: -5653594.852941176
Capital expenditures: 0
Operating cash flow: -3051569.8529411764
Net tangible assets: 7493743.382352941
Owner earnings: -5653594.852941176
Return on net tangible assets (%): -75.44420144216386
Buffett classification: The Gruesome
Stock price: 0.1838235294117647
Shares outstanding: 511063160
Book value: 7493743.382352941
P/B ratio: 12.536516001436885
Market cap (USD): 93945433.8235294
Debt to equity: 0
Current ratio: 12.887532245262426
Quick ratio: 12.887532245262426
Free cash flow (dilution-adjusted): -4462987.5
Buyback yield (%): 0
Retained earnings: -42466794.85294117
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -53.313839771427276
Rule of 40 score: 0
Financial ratios for MGG.V — annual report dated 2024-04-30
Total revenue: 0
Operating income: -1492532.116788321
Net income: -2725154.744525547
Capital expenditures: 0
Operating cash flow: -1147660.5839416056
Net tangible assets: 5543511.678832117
Owner earnings: -2725154.744525547
Return on net tangible assets (%): -49.15935786572874
Buffett classification: The Gruesome
Stock price: 0.1751824817518248
Shares outstanding: 511063160
Book value: 5543511.678832117
P/B ratio: 16.150288461120656
Market cap (USD): 89529312.70072992
Debt to equity: 0
Current ratio: 2.0251524030724006
Quick ratio: 2.0251524030724006
Free cash flow (dilution-adjusted): -1408378.1021897807
Buyback yield (%): 0
Retained earnings: -44881972.992700726
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -26.375230228886753
Rule of 40 score: 0
Financial ratios for MGG.V — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1798561151079137
Shares outstanding: 511063160
Market cap (USD): 91917834.53237411
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MGG.V — quarterly report dated 2025-01-31
Total revenue: 0
Operating income: -468713.1034482759
Net income: -500962.0689655173
Capital expenditures: 0
Operating cash flow: -513090.3448275862
Net tangible assets: 6369460.689655173
Owner earnings: -500962.0689655173
Return on net tangible assets (%): -7.865062575535546
Buffett classification: The Gruesome
Stock price: 0.13793103448275862
Shares outstanding: 511063160
Book value: 6369460.689655173
P/B ratio: 11.067101875566143
Market cap (USD): 70491470.34482759
Debt to equity: 0
Current ratio: 13.05535081910575
Quick ratio: 13.05535081910575
Free cash flow (dilution-adjusted): -512838.6206896552
Buyback yield (%): 0
Retained earnings: -44875064.82758621
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.234984060624345
Rule of 40 score: 0
Financial ratios for MGG.V — annual report dated 2025-04-30
Total revenue: 0
Operating income: -3301165.2173913047
Net income: -4147394.9275362324
Capital expenditures: 0
Operating cash flow: -3070777.5362318843
Net tangible assets: 5139749.275362319
Owner earnings: -4147394.9275362324
Return on net tangible assets (%): -80.69255337837208
Buffett classification: The Gruesome
Stock price: 0.10144927536231886
Shares outstanding: 511063160
Book value: 5139749.275362319
P/B ratio: 10.08745455637463
Market cap (USD): 51846987.24637682
Debt to equity: 0
Current ratio: 3.6393467156479336
Quick ratio: 3.6393467156479336
Free cash flow (dilution-adjusted): -3106108.6956521743
Buyback yield (%): 0
Retained earnings: -48704136.23188406
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -62.32999044720281
Rule of 40 score: 0
Financial ratios for MGG.V — quarterly report dated 2025-04-30
Total revenue: 0
Operating income: -457890.57971014496
Net income: -1552800.0000000002
Capital expenditures: 0
Operating cash flow: -473220.2898550725
Net tangible assets: 5139749.275362319
Owner earnings: -1552800.0000000002
Return on net tangible assets (%): -30.211590426082363
Buffett classification: The Gruesome
Stock price: 0.10144927536231886
Shares outstanding: 511063160
Book value: 5139749.275362319
P/B ratio: 10.08745455637463
Market cap (USD): 51846987.24637682
Debt to equity: 0
Current ratio: 3.6393467156479336
Quick ratio: 3.6393467156479336
Free cash flow (dilution-adjusted): -473220.2898550725
Buyback yield (%): 0
Retained earnings: -48704136.23188406
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.645527739369264
Rule of 40 score: 0
Financial ratios for MGG.V — quarterly report dated 2025-07-31
Total revenue: 0
Operating income: -1424505.0724637683
Net income: -1355768.115942029
Capital expenditures: 0
Operating cash flow: -747460.1449275363
Net tangible assets: 10575239.130434783
Owner earnings: -1355768.115942029
Return on net tangible assets (%): -12.820212377422513
Buffett classification: The Gruesome
Stock price: 0.16666666666666669
Shares outstanding: 511063160
Book value: 10575239.130434785
P/B ratio: 8.054398797299955
Market cap (USD): 85177193.33333334
Debt to equity: 0
Current ratio: 6.275132438978533
Quick ratio: 6.275132438978533
Free cash flow (dilution-adjusted): -747460.1449275363
Buyback yield (%): 0
Retained earnings: -50059904.34782609
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.273731028647864
Rule of 40 score: 0
Financial ratios for MGG.V — quarterly report dated 2025-10-31
Total revenue: 0
Operating income: -3153055
Net income: -3110192.142857143
Capital expenditures: 0
Operating cash flow: -3210739.285714286
Net tangible assets: 7450221.428571429
Owner earnings: -3110192.142857143
Return on net tangible assets (%): -41.7463047598777
Buffett classification: The Gruesome
Stock price: 0.22142857142857145
Shares outstanding: 511063160
Book value: 7450221.428571428
P/B ratio: 15.189345244772209
Market cap (USD): 113163985.42857143
Debt to equity: 0
Current ratio: 3.4669314252682293
Quick ratio: 3.4669314252682293
Free cash flow (dilution-adjusted): -3210739.285714286
Buyback yield (%): 0
Retained earnings: -52454955
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -41.46297637397371
Rule of 40 score: 0
Financial ratios for NZ.V — annual report dated 2021-12-31
Total revenue: 3498680.1369863013
Gross profit: 216827.39726027398
Operating income: -751810.2739726028
Net income: -514431.5068493151
Capital expenditures: 1660043.1506849315
Operating cash flow: -135705.4794520548
Depreciation & amortization: 414762.3287671233
Net tangible assets: 997728.0821917808
Owner earnings: -1759712.3287671234
Return on net tangible assets (%): -176.37193541765782
Buffett classification: The Gruesome
Stock price: 0.10236220472440945
Shares outstanding: 55870187
Book value: 1103795.8904109597
P/B ratio: 5.1812074762805755
Market cap (USD): 5718995.519685039
Debt to equity: 1.2954648405067932
Current ratio: 0.6326852948636548
Quick ratio: 0.4869801883725429
Interest coverage ratio: -4.591150168564234
COGS to revenue (%): 93.80259444217027
SG&A to revenue (%): 31.934664990104878
Free cash flow (dilution-adjusted): -1795748.6301369863
Buyback yield (%): 0
Retained earnings: -74059701.36986302
Inventory turnover: 7.730328540636817
Receivables turnover: 3.3879453744727135
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.218991217653658
FCF margin (%): -51.32645911677457
Rule of 40 score: -51.32645911677457
Financial ratios for NZ.V — annual report dated 2022-12-31
Total revenue: 2967967.7215189873
Gross profit: 1054877.8481012657
Operating income: 254241.7721518987
Net income: 1131285.4430379746
Capital expenditures: 419073.41772151896
Operating cash flow: 455751.8987341772
Depreciation & amortization: 265298.7341772152
Net tangible assets: 2089449.3670886075
Owner earnings: 977510.7594936709
Return on net tangible assets (%): 46.78317526572624
Capex to operating income (%): 164.83263712901604
Buffett classification: The Gruesome
Stock price: 0.044117647058823525
P/E ratio: 2.1788145567906247
Shares outstanding: 55870187
Book value: 2184735.4430379746
P/B ratio: 1.128219528378671
Market cap (USD): 2464861.1911764704
Debt to equity: 0.6627387610584603
Current ratio: 0.523306743155085
Quick ratio: 0.36488720331788654
Interest coverage ratio: 0.8243575194288423
COGS to revenue (%): 64.45790698958862
SG&A to revenue (%): 35.48583834695735
Free cash flow (dilution-adjusted): 36678.48101265822
Buyback yield (%): 0
Retained earnings: -67270141.7721519
Inventory turnover: 4.574401239743213
Receivables turnover: 5.071940080577563
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4270657160680376
FCF margin (%): 1.235811317849724
Revenue growth (%): -15.168932131202478
Rule of 40 score: -13.933120813352755
Financial ratios for NZ.V — annual report dated 2023-12-31
Total revenue: 1213358.8607594937
Gross profit: -234324.68354430379
Operating income: -881756.9620253164
Net income: -1227033.5443037974
Capital expenditures: 76288.60759493671
Operating cash flow: -888708.2278481012
Depreciation & amortization: 240582.91139240505
Net tangible assets: 2183863.2911392404
Owner earnings: -1062739.240506329
Return on net tangible assets (%): -48.66326774291524
Buffett classification: The Gruesome
Stock price: 0.6060606060606061
Shares outstanding: 55870187
Book value: 2275318.3544303803
P/B ratio: 14.881750207836886
Market cap (USD): 33860719.3939394
Debt to equity: 0.7033916244297985
Current ratio: 1.77576365889154
Quick ratio: 1.2995341625549552
Interest coverage ratio: -2.6122066326291455
COGS to revenue (%): 119.31206761020641
SG&A to revenue (%): 68.55637165791998
Free cash flow (dilution-adjusted): -964996.8354430379
Buyback yield (%): 0
Retained earnings: -68584020.88607594
Inventory turnover: 3.6577190867135956
Receivables turnover: 4.306025178846175
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.982376488533252
FCF margin (%): -79.53103295747185
Revenue growth (%): -59.118192156803374
Rule of 40 score: -138.64922511427523
Financial ratios for NZ.V — quarterly report dated 2024-09-30
Total revenue: 184922.29299363057
Gross profit: -214535.03184713374
Operating income: -597045.8598726115
Net income: -780609.5541401274
Capital expenditures: 976387.898089172
Operating cash flow: -295031.84713375795
Depreciation & amortization: 47941.40127388535
Net tangible assets: 3345935.0318471338
Owner earnings: -1709056.0509554138
Return on net tangible assets (%): -51.07857847472681
Buffett classification: The Gruesome
Stock price: 0.6666666666666666
Shares outstanding: 55870187
Book value: 3439222.9299363066
P/B ratio: 10.830002035960819
Market cap (USD): 37246791.33333333
Debt to equity: 0.49630952777808635
Current ratio: 0.7106543302752601
Quick ratio: 0.5991057584759713
Interest coverage ratio: -7.428886176671052
COGS to revenue (%): 216.01361219035024
SG&A to revenue (%): 194.2816400760519
Free cash flow (dilution-adjusted): -1271419.7452229299
Buyback yield (%): 0
Retained earnings: -70921489.17197452
Inventory turnover: 1.045109060640349
Receivables turnover: 0.2129144390909291
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.897495123212918
FCF margin (%): -687.5427103138519
Rule of 40 score: -687.5427103138519
Financial ratios for NZ.V — quarterly report dated 2024-12-31
Total revenue: 150926.5536723164
Gross profit: -165782.48587570622
Operating income: -974253.6723163842
Net income: -2655337.2881355933
Capital expenditures: 2034172.3163841807
Operating cash flow: 23796.610169491527
Depreciation & amortization: 61166.101694915254
Net tangible assets: 2259812.9943502825
Owner earnings: -4628343.502824859
Return on net tangible assets (%): -204.81090755722252
Buffett classification: The Gruesome
Stock price: 0.6993006993006994
Shares outstanding: 55870187
Book value: 2337551.4124293774
P/B ratio: 16.714096909875447
Market cap (USD): 39070060.839160845
Debt to equity: 0.6644550070018705
Current ratio: 0.4325585215573316
Quick ratio: 0.3249241881732563
Interest coverage ratio: -12.713277794161014
COGS to revenue (%): 198.71939806842852
SG&A to revenue (%): 545.3425170322677
Free cash flow (dilution-adjusted): -2010375.7062146892
Buyback yield (%): 0
Retained earnings: -65298376.27118644
Inventory turnover: 0.9737834104679253
Receivables turnover: 0.6048242853455654
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.883418442044828
FCF margin (%): -1332.0225350003743
Revenue growth (%): -18.3837971998785
Rule of 40 score: -1350.4063322002528
Financial ratios for NZ.V — annual report dated 2024-12-31
Total revenue: 659241.2429378531
Gross profit: -614784.7457627119
Operating income: -2543385.3107344634
Net income: -4559915.254237288
Capital expenditures: 3272397.175141243
Operating cash flow: -1108545.197740113
Depreciation & amortization: 189860.45197740113
Net tangible assets: 2259812.9943502825
Owner earnings: -7642451.97740113
Return on net tangible assets (%): -338.1895757086045
Buffett classification: The Gruesome
Stock price: 0.6993006993006994
Shares outstanding: 55870187
Book value: 2337551.4124293774
P/B ratio: 16.714096909875447
Market cap (USD): 39070060.839160845
Debt to equity: 0.6644550070018705
Current ratio: 0.3608781160640122
Quick ratio: 0.25324378267993697
Interest coverage ratio: -8.577733826451965
COGS to revenue (%): 193.25641445352773
SG&A to revenue (%): 293.0038556566914
Free cash flow (dilution-adjusted): -4925519.774011299
Buyback yield (%): 0
Retained earnings: -85243218.07909605
Inventory turnover: 4.136516304656874
Receivables turnover: 14.839467392410215
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -36.244033285829616
FCF margin (%): -747.1498221290183
Revenue growth (%): -45.668073621252866
Rule of 40 score: -792.8178957502712
Financial ratios for NZ.V — quarterly report dated 2025-03-31
Total revenue: 139456
Gross profit: -171511.42857142858
Operating income: -526756
Net income: -603754.2857142857
Capital expenditures: 184350.85714285713
Operating cash flow: -380389.14285714284
Depreciation & amortization: 43278.28571428572
Net tangible assets: 1729699.4285714286
Owner earnings: -744826.8571428572
Return on net tangible assets (%): -43.061057016016655
Buffett classification: The Gruesome
Stock price: 0.18881118881118883
Shares outstanding: 55870187
Book value: 1808911.999999999
P/B ratio: 5.831636047841704
Market cap (USD): 10548916.426573427
Debt to equity: 0.8841977940330988
Current ratio: 0.250404030801407
Quick ratio: 0.13344717604275247
Interest coverage ratio: -7.343974315054852
COGS to revenue (%): 222.98605192421164
SG&A to revenue (%): 248.21674424703338
Free cash flow (dilution-adjusted): -564740
Buyback yield (%): 0
Retained earnings: -66612957.71428572
Inventory turnover: 0.8690305282438555
Receivables turnover: 0.4828187906185394
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.9042191682907585
FCF margin (%): -404.9592703074805
Revenue growth (%): -7.6000898405330615
Rule of 40 score: -412.5593601480136
Financial ratios for NZ.V — quarterly report dated 2025-06-30
Total revenue: 141972.7272727273
Gross profit: -579657.5757575758
Operating income: -909292.7272727273
Net income: -991268.4848484849
Capital expenditures: 1251.5151515151515
Operating cash flow: -6346.060606060606
Depreciation & amortization: 82750.90909090909
Net tangible assets: 879995.1515151516
Owner earnings: -909769.0909090909
Return on net tangible assets (%): -103.3834208452939
Buffett classification: The Gruesome
Stock price: 0.16058394160583941
Shares outstanding: 55870187
Book value: 965160.6060606074
P/B ratio: 9.295711812498013
Market cap (USD): 8971854.84671533
Debt to equity: 2.084711290003545
Current ratio: 0.34993901930965865
Quick ratio: 0.20939399860351052
Interest coverage ratio: -11.871977274165982
COGS to revenue (%): 508.28797677744336
SG&A to revenue (%): 218.70098823931184
Free cash flow (dilution-adjusted): -7597.575757575758
Buyback yield (%): 0
Retained earnings: -71603489.0909091
Inventory turnover: 2.0640239357368455
Receivables turnover: 0.3243051296569846
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.400303864643078
FCF margin (%): -5.351433267166121
Revenue growth (%): 1.804674788268195
Rule of 40 score: -3.5467584788979263
Financial ratios for NZ.V — quarterly report dated 2025-09-30
Total revenue: 260835.26011560694
Gross profit: -231524.2774566474
Operating income: -620680.3468208093
Net income: 465902.8901734104
Capital expenditures: 17097.109826589596
Operating cash flow: -1197637.5722543353
Depreciation & amortization: 100487.8612716763
Net tangible assets: 3142657.8034682083
Owner earnings: 549293.6416184971
Return on net tangible assets (%): 17.478633563358432
Buffett classification: The Gruesome
Stock price: 0.2302158273381295
P/E ratio: 6.901760857801108
Shares outstanding: 55870187
Book value: 3220553.179190751
P/B ratio: 3.993786349142968
Market cap (USD): 12862201.323741008
Debt to equity: 0.010868595618783046
Current ratio: 0.6599626452579812
Quick ratio: 0.37190904229863114
Interest coverage ratio: -8.186647047163051
COGS to revenue (%): 188.76264556948
SG&A to revenue (%): 137.97936819244535
Free cash flow (dilution-adjusted): -1214734.682080925
Buyback yield (%): 0
Retained earnings: -88304420.23121387
Inventory turnover: 1.0122703833945168
Receivables turnover: 1.0385696234870088
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.469103556212504
FCF margin (%): -465.7095369477778
Revenue growth (%): 83.72208883086867
Rule of 40 score: -381.98744811690915
Financial ratios for NZ.V — annual report dated 2025-12-31
Total revenue: 963018.4971098267
Gross profit: -548654.3352601156
Operating income: -1735711.5606936417
Net income: -4104490.1734104045
Capital expenditures: 909725.4335260115
Operating cash flow: -1719330.0578034683
Depreciation & amortization: 369146.82080924854
Net tangible assets: 181817.9190751445
Owner earnings: -4645068.786127168
Return on net tangible assets (%): -2554.7915242652084
Buffett classification: The Gruesome
Stock price: 0.1678832116788321
Shares outstanding: 55870187
Book value: 263357.22543352563
P/B ratio: 35.615755046084615
Market cap (USD): 9379666.430656934
Debt to equity: 0.045297712068269276
Current ratio: 0.54562128727927
Quick ratio: 0.47061596929042065
Interest coverage ratio: -6.389249192508522
COGS to revenue (%): 156.97235690765189
SG&A to revenue (%): 123.26421859975439
Free cash flow (dilution-adjusted): -2629055.49132948
Buyback yield (%): 0
Retained earnings: -91318650.86705202
Inventory turnover: 11.716976482658817
Receivables turnover: 1.2644282180829063
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -31.563278266829958
FCF margin (%): -273.0015570022485
Revenue growth (%): 46.07983153757429
Rule of 40 score: -226.92172546467418
Financial ratios for NZ.V — quarterly report dated 2025-12-31
Total revenue: 422228.32369942195
Gross profit: 405737.5722543353
Operating income: 280519.65317919076
Net income: -3014185.549132948
Capital expenditures: 704952.6011560693
Operating cash flow: -130853.17919075144
Depreciation & amortization: 145956.06936416184
Net tangible assets: 181817.9190751445
Owner earnings: -3573182.0809248555
Return on net tangible assets (%): -1965.2529844696307
Capex to operating income (%): 251.30239295774354
Buffett classification: The Gruesome
Stock price: 0.1678832116788321
Shares outstanding: 55870187
Book value: 263357.22543352563
P/B ratio: 35.615755046084615
Market cap (USD): 9379666.430656934
Debt to equity: 0.045297712068269276
Current ratio: 0.54562128727927
Quick ratio: 0.47061596929042065
Interest coverage ratio: 5.583604671230512
COGS to revenue (%): 3.9056478496279716
SG&A to revenue (%): 43.08711693396582
Free cash flow (dilution-adjusted): -835805.7803468208
Buyback yield (%): 0
Retained earnings: -91318650.86705202
Inventory turnover: 0.12781981836673434
Receivables turnover: 0.5543791822915599
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.101147029908046
FCF margin (%): -197.95114004285003
Revenue growth (%): 61.87547784462984
Rule of 40 score: -136.0756621982202
Financial ratios for OPCH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.44
Shares outstanding: 157027504
Market cap (USD): 4465862213.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OPCH — annual report dated 2022-12-31
Total revenue: 3944735000
Gross profit: 866918000
Operating income: 240231000
Net income: 150556000
Capital expenditures: 35358000
Operating cash flow: 267547000
Depreciation & amortization: 65434000
Net tangible assets: -511436000
Owner earnings: 180632000
Return on net tangible assets (%): -35.318593137753304
Capex to operating income (%): 14.718333603906238
Buffett classification: The Great
Stock price: 30.09
P/E ratio: 31.38338953851059
Shares outstanding: 157027504
Book value: 1386103000
P/B ratio: 3.4088069900721663
Market cap (USD): 4724957595.36
Debt to equity: 0.8332894453009625
Current ratio: 1.7587994007262744
Quick ratio: 1.3620883309660725
Effective tax rate (%): 26.83216049142724
Interest coverage ratio: 4.464762294167937
COGS to revenue (%): 78.02341602160855
SG&A to revenue (%): 14.351331585011415
Free cash flow (dilution-adjusted): 215406000
Buyback yield (%): 0
Retained earnings: 190423000
Inventory turnover: 13.723039401465126
Receivables turnover: 10.44846666066292
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.429754061199136
FCF margin (%): 5.460594944907579
Rule of 40 score: 5.460594944907579
Financial ratios for OPCH — annual report dated 2023-12-31
Total revenue: 4302324000
Gross profit: 981223000
Operating income: 314595000
Net income: 267090000
Capital expenditures: 41866000
Operating cash flow: 371295000
Depreciation & amortization: 62200000
Net tangible assets: -453970000
Owner earnings: 287424000
Return on net tangible assets (%): -63.31343480846752
Capex to operating income (%): 13.307903812838727
Buffett classification: The Great
Stock price: 33.69
P/E ratio: 19.807018644501852
Shares outstanding: 157027504
Book value: 1421672000
P/B ratio: 3.721151299146357
Market cap (USD): 5290256609.759999
Debt to equity: 0.8204508494223702
Current ratio: 1.7697542814353342
Quick ratio: 1.3266036884470387
Effective tax rate (%): 25.54816553400494
Interest coverage ratio: 6.138678582578832
COGS to revenue (%): 77.19318675209027
SG&A to revenue (%): 14.118578703045145
Free cash flow (dilution-adjusted): 298950000
Buyback yield (%): 4.730602283796466
Retained earnings: 457513000
Inventory turnover: 12.120629625844877
Receivables turnover: 11.39211667699347
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.105739504664978
FCF margin (%): 6.948570121636585
Revenue growth (%): 9.0649688762363
Rule of 40 score: 16.013538997872885
Financial ratios for OPCH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.3
Shares outstanding: 157027504
Market cap (USD): 4914960875.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OPCH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.2
Shares outstanding: 157027504
Market cap (USD): 3643038092.7999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OPCH — annual report dated 2024-12-31
Total revenue: 4998202000
Gross profit: 1012993000
Operating income: 321833000
Net income: 211823000
Capital expenditures: 35606000
Operating cash flow: 323392000
Depreciation & amortization: 63498000
Net tangible assets: -437018000
Owner earnings: 239715000
Return on net tangible assets (%): -54.85243170761846
Capex to operating income (%): 11.063501878303343
Buffett classification: The Great
Stock price: 23.2
P/E ratio: 17.198501073065717
Shares outstanding: 157027504
Book value: 1404238000
P/B ratio: 2.594316699021106
Market cap (USD): 3643038092.7999997
Debt to equity: 0.8673551064705556
Current ratio: 1.6953583047275766
Quick ratio: 1.1978475823756065
Effective tax rate (%): 25.308974996385743
Interest coverage ratio: 6.56413551163597
COGS to revenue (%): 79.73285193355531
SG&A to revenue (%): 12.609554395760716
Free cash flow (dilution-adjusted): 251643000
Buyback yield (%): 6.9372318807064
Retained earnings: 669336000
Inventory turnover: 10.267690547778972
Receivables turnover: 12.198680604198344
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.183273981610366
FCF margin (%): 5.0346704675001135
Revenue growth (%): 16.17446756683132
Rule of 40 score: 21.209138034331435
Financial ratios for OPCH — quarterly report dated 2025-03-31
Total revenue: 1332972000
Gross profit: 263052000
Operating income: 79188000
Net income: 46742000
Capital expenditures: 9371000
Operating cash flow: -7214000
Depreciation & amortization: 16373000
Net tangible assets: -592109000
Owner earnings: 53744000
Return on net tangible assets (%): -9.076707160337033
Capex to operating income (%): 11.833863716724755
Buffett classification: The Great
Stock price: 34.95
P/E ratio: 29.35321159128835
Shares outstanding: 157027504
Book value: 1350834000
P/B ratio: 4.062757722118336
Market cap (USD): 5488111264.8
Debt to equity: 0.9053369992167801
Current ratio: 1.540465821450991
Quick ratio: 1.0233681396287329
Effective tax rate (%): 26.45540940273145
Interest coverage ratio: 5.985035144735847
COGS to revenue (%): 80.2657520187971
SG&A to revenue (%): 12.612267924607568
Free cash flow (dilution-adjusted): -25386000
Buyback yield (%): 1.8261655998632953
Retained earnings: 716078000
Inventory turnover: 2.8992450560110994
Receivables turnover: 2.796548403542229
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0517382707047696
FCF margin (%): -1.9044661103158955
Rule of 40 score: -1.9044661103158955
Financial ratios for OPCH — quarterly report dated 2025-06-30
Total revenue: 1416085000
Gross profit: 269043000
Operating income: 82710000
Net income: 50523000
Capital expenditures: 9095000
Operating cash flow: 90333000
Depreciation & amortization: 16953000
Net tangible assets: -573624000
Owner earnings: 58381000
Return on net tangible assets (%): -10.1775727654352
Capex to operating income (%): 10.996251964695926
Buffett classification: The Great
Stock price: 32.48
P/E ratio: 52.43667639870456
Shares outstanding: 157027504
Book value: 1359948000
P/B ratio: 3.7503296669578536
Market cap (USD): 5100253329.919999
Debt to equity: 0.9034911628974049
Current ratio: 1.5191295468059254
Quick ratio: 0.9975013572555002
Effective tax rate (%): 26.63045845979582
Interest coverage ratio: 5.725064027133661
COGS to revenue (%): 81.00092861657315
SG&A to revenue (%): 12.011425867797485
Free cash flow (dilution-adjusted): 70526000
Buyback yield (%): 1.0236158210756738
Retained earnings: 766601000
Inventory turnover: 2.8424352359853495
Receivables turnover: 2.942495942882434
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.169929856055827
FCF margin (%): 4.980350755780903
Revenue growth (%): 6.235164729641733
Rule of 40 score: 11.215515485422635
Financial ratios for OPCH — quarterly report dated 2025-09-30
Total revenue: 1435016000
Gross profit: 272902000
Operating income: 84507000
Net income: 51816000
Capital expenditures: 9195000
Operating cash flow: 139437000
Depreciation & amortization: 17048000
Net tangible assets: -566435000
Owner earnings: 59669000
Return on net tangible assets (%): -10.53413012967066
Capex to operating income (%): 10.88075544037772
Buffett classification: The Great
Stock price: 27.76
P/E ratio: 29.239698627189245
Shares outstanding: 157027504
Book value: 1358659000
P/B ratio: 3.2083720131688676
Market cap (USD): 4359083511.04
Debt to equity: 0.9393122188864167
Current ratio: 1.5569324655968035
Quick ratio: 1.0523567008857806
Effective tax rate (%): 24.868415329070427
Interest coverage ratio: 5.973914887600735
COGS to revenue (%): 80.98265106451775
SG&A to revenue (%): 11.993176382702353
Free cash flow (dilution-adjusted): 119117000
Buyback yield (%): 1.4328241209836017
Retained earnings: 818417000
Inventory turnover: 2.7954046324114854
Receivables turnover: 3.0242697576396207
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.18181253409811
FCF margin (%): 8.300743685087832
Revenue growth (%): 1.3368547791975764
Rule of 40 score: 9.637598464285409
Financial ratios for OPCH — quarterly report dated 2025-12-31
Total revenue: 1465446000
Gross profit: 282898000
Operating income: 91501000
Net income: 58504000
Capital expenditures: 13646000
Operating cash flow: 35891000
Depreciation & amortization: 20316000
Net tangible assets: -589528000
Owner earnings: 65174000
Return on net tangible assets (%): -11.055284905890813
Capex to operating income (%): 14.913498213134282
Buffett classification: The Great
Stock price: 31.86
P/E ratio: 24.100471023628874
Shares outstanding: 157027504
Book value: 1326393000
P/B ratio: 3.7718053981286093
Market cap (USD): 5002896277.44
Debt to equity: 0.9600073281448258
Current ratio: 1.5252559842189286
Quick ratio: 0.9571603235312559
Effective tax rate (%): 28.2300407282006
Interest coverage ratio: 7.185566200722476
COGS to revenue (%): 80.69543333565345
SG&A to revenue (%): 11.746389836268275
Free cash flow (dilution-adjusted): 12927000
Buyback yield (%): 1.9001793107060894
Retained earnings: 876921000
Inventory turnover: 2.509923612275522
Receivables turnover: 3.0944915808989664
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.483866447915243
FCF margin (%): 0.8821205284943969
Revenue growth (%): 2.1205338477062274
Rule of 40 score: 3.002654376200624
Financial ratios for OPCH — annual report dated 2025-12-31
Total revenue: 5649519000
Gross profit: 1087895000
Operating income: 337906000
Net income: 207585000
Capital expenditures: 41307000
Operating cash flow: 258447000
Depreciation & amortization: 70690000
Net tangible assets: -589528000
Owner earnings: 236968000
Return on net tangible assets (%): -40.196224776431315
Capex to operating income (%): 12.224405603925351
Buffett classification: The Great
Stock price: 31.86
P/E ratio: 24.100471023628874
Shares outstanding: 157027504
Book value: 1326393000
P/B ratio: 3.7718053981286093
Market cap (USD): 5002896277.44
Debt to equity: 0.9600073281448258
Current ratio: 1.5252559842189286
Quick ratio: 0.9571603235312559
Effective tax rate (%): 26.622481442205725
Interest coverage ratio: 6.193518824003813
COGS to revenue (%): 80.74358188723677
SG&A to revenue (%): 12.079807148183766
Free cash flow (dilution-adjusted): 177184000
Buyback yield (%): 6.195431262440705
Retained earnings: 876921000
Inventory turnover: 9.68191378948061
Receivables turnover: 11.929739466093427
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.865644921358763
FCF margin (%): 3.1362669990135443
Revenue growth (%): 13.031025956934114
Rule of 40 score: 16.16729295594766
Financial ratios for PAGE.L — annual report dated 2022-12-31
Total revenue: 2397936144.5783134
Gross profit: 1296739759.0361447
Operating income: 236239759.03614458
Net income: 167484337.3493976
Capital expenditures: 23978313.25301205
Operating cash flow: 222616867.46987954
Depreciation & amortization: 73002409.63855422
Net tangible assets: 376148192.77108437
Owner earnings: 216508433.73493975
Return on net tangible assets (%): 57.55934440091862
Capex to operating income (%): 10.14999056502736
Buffett classification: The Great
Stock price: 0.04542168674698795
P/E ratio: 0.08444167915072079
Shares outstanding: 311363573
Book value: 424340963.85542166
P/B ratio: 0.03332852560057694
Market cap (USD): 14142658.677228916
Debt to equity: 0.3118428860628672
Current ratio: 1.717360594141818
Quick ratio: 1.717360594141818
Effective tax rate (%): 28.479260776061654
Interest coverage ratio: 69.60560880369187
COGS to revenue (%): 45.92267346367634
SG&A to revenue (%): 44.225531292723105
Free cash flow (dilution-adjusted): 177238554.21686748
Buyback yield (%): 0
Retained earnings: 328565060.2409639
Receivables turnover: 6.465455407784715
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 43.213383699250244
FCF margin (%): 7.391295828189602
Rule of 40 score: 7.391295828189602
Financial ratios for PAGE.L — annual report dated 2023-12-31
Total revenue: 2544687341.772152
Gross profit: 1274850632.9113925
Operating income: 150398734.1772152
Net income: 97554430.37974682
Capital expenditures: 33874683.5443038
Operating cash flow: 193681012.65822783
Depreciation & amortization: 84532911.39240506
Net tangible assets: 347329113.9240506
Owner earnings: 148212658.22784808
Return on net tangible assets (%): 42.6721090418747
Capex to operating income (%): 22.523250431342845
Buffett classification: The Great
Stock price: 0.054303797468354426
P/E ratio: 0.17332092803368454
Shares outstanding: 311363573
Book value: 387959493.67088604
P/B ratio: 0.043582447866474375
Market cap (USD): 16908224.40721519
Debt to equity: 0.3619489180653076
Current ratio: 1.6357525724015927
Quick ratio: 1.6357525724015927
Effective tax rate (%): 34.37446779522463
Interest coverage ratio: 32.86721991701245
COGS to revenue (%): 49.90148251283513
SG&A to revenue (%): 44.18821441344911
Free cash flow (dilution-adjusted): 146994936.70886075
Buyback yield (%): 131.22967297186
Retained earnings: 315865822.7848101
Receivables turnover: 7.431584278468659
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.503421766207456
FCF margin (%): 5.776542143149565
Revenue growth (%): 6.1198959582656185
Rule of 40 score: 11.896438101415184